Rovaldi Christopher (CIK 0001706040)

Latest company ownership

Shares held
60,000
Last filed at
Feb 19, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2022Q2 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Apr 6, 2022 Apr 8, 2022 Keros Therapeutics, Inc. COO Sell 10.0 -1,728 -100.00% $112.3K
Apr 1, 2022 Apr 5, 2022 Keros Therapeutics, Inc. COO Sell 13.8 -864 -100.00% $49.7K